| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Cellular Biology, University of Georgia, Athens, GA 30602
Amastigotes of Trypanosoma cruzi express surface proteins that, when released into the host cell cytoplasm, are processed and presented on the surface of infected cells in the context of MHC class I molecules to be recognized by CD8+ CTL. To further understand the role of CTL in T. cruzi infection, we used the available MHC class I peptide binding motifs to identify potential CTL target epitopes in two recently described T. cruzi amastigote surface proteins, ASP-1 and ASP-2. The predicted amino acid sequences of ASP-1 and ASP-2 were screened for H-2b allele-specific class I peptide motifs, and four peptides (PA11, PA12, PA13, and PA14) and six peptides (PA5, PA6, PA7, PA8, PA9, and PA10) were synthesized from ASP-1 and ASP-2, respectively. The majority of the peptides bound to some degree to H-2b class I MHC molecules, and six of 10 of the peptides stimulated spleen cells from T. cruzi-infected mice to lyse target cells sensitized with the homologous peptides. Short term T cell lines specific for three of these peptides also lysed T. cruzi-infected target cells. These results demonstrate that ASP-1 and ASP-2 are targets of in vivo generated CTLs and that this CTL response induced by T. cruzi infection is parasite and peptide specific, MHC restricted, and CD8 dependent.
This article has been cited by other articles:
|
|
 |
|
  V. Bhatia and N. J. Garg Previously Unrecognized Vaccine Candidates Control Trypanosoma cruzi Infection and Immunopathology in Mice Clin. Vaccine Immunol., August 1, 2008; 15(8): 1158 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Tzelepis, B. C. G. de Alencar, M. L. O. Penido, C. Claser, A. V. Machado, O. Bruna-Romero, R. T. Gazzinelli, and M. M. Rodrigues Infection with Trypanosoma cruzi Restricts the Repertoire of Parasite-Specific CD8+ T Cells Leading to Immunodominance J. Immunol., February 1, 2008; 180(3): 1737 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. Cazorla, P. D. Becker, F. M. Frank, T. Ebensen, M. J. Sartori, R. S. Corral, E. L. Malchiodi, and C. A. Guzman Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi Infect. Immun., January 1, 2008; 76(1): 324 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tzelepis, B. C. G. de Alencar, M. L. O. Penido, R. T. Gazzinelli, P. M. Persechini, and M. M. Rodrigues Distinct Kinetics of Effector CD8+ Cytotoxic T Cells after Infection with Trypanosoma cruzi in Naive or Vaccinated Mice Infect. Immun., April 1, 2006; 74(4): 2477 - 2481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Cummings and R. L. Tarleton Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice Infect. Immun., July 1, 2004; 72(7): 4081 - 4089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Boscardin, S. S. Kinoshita, A. E. Fujimura, and M. M. Rodrigues Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection Infect. Immun., May 1, 2003; 71(5): 2744 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Garg and R. L. Tarleton Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection Infect. Immun., October 1, 2002; 70(10): 5547 - 5555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. Overtvelt, M. Andrieu, V. Verhasselt, F. Connan, J. Choppin, V. Vercruysse, M. Goldman, A. Hosmalin, and B. Vray Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8+ T lymphocytes Int. Immunol., October 1, 2002; 14(10): 1135 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Katae, Y. Miyahira, K. Takeda, H. Matsuda, H. Yagita, K. Okumura, T. Takeuchi, T. Kamiyama, A. Ohwada, Y. Fukuchi, et al. Coadministration of an Interleukin-12 Gene and a Trypanosoma cruzi Gene Improves Vaccine Efficacy Infect. Immun., September 1, 2002; 70(9): 4833 - 4840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Fujimura, S. S. Kinoshita, V. L. Pereira-Chioccola, and M. M. Rodrigues DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene Infect. Immun., September 1, 2001; 69(9): 5477 - 5486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Moretto, L. Casciotti, B. Durell, and I. A. Khan Lack of CD4+ T Cells Does Not Affect Induction of CD8+ T-Cell Immunity against Encephalitozoon cuniculi Infection Infect. Immun., November 1, 2000; 68(11): 6223 - 6232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Quanquin, C. Galaviz, D. L. Fouts, R. A. Wrightsman, and J. E. Manning Immunization of Mice with a TolA-Like Surface Protein of Trypanosoma cruzi Generates CD4+ T-Cell-Dependent Parasiticidal Activity Infect. Immun., September 1, 1999; 67(9): 4603 - 4612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Miyahira, S. Kobayashi, T. Takeuchi, T. Kamiyama, T. Nara, J. Nakajima-Shimada, and T. Aoki Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi Int. Immunol., February 1, 1999; 11(2): 133 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Wizel, N. Garg, and R. L. Tarleton Vaccination with Trypomastigote Surface Antigen 1-Encoding Plasmid DNA Confers Protection against Lethal Trypanosoma cruzi Infection Infect. Immun., November 1, 1998; 66(11): 5073 - 5081. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
